Europe Glucose Monitoring Devices Market - Industry Analysis and Market Forecast 2017 - 2022

  • ID: 4387545
  • Report
  • Region: Europe
  • 120 pages
  • Mordor Intelligence
1 of 4
Europeglucose monitoring device market is forecasted to reach USD 4.83 billion by 2019 at a CAGR of 9.44 %.

EuropeGlucose Monitoring Devices Market- Market Dynamics

The direct and indirect costs of diabetes care are increasing with the rise in the prevalence of various complications due to the disease. In the European Union, about £93 billion were lost due to these direct and indirect costs linked to diabetes. This increased spending is putting pressure on governments to take the steps essential to keep the disease in check and avoid complications in order to ensure that these losses are kept to a minimum. This is expected to help boost the sales of blood glucose meters, as keeping a check on blood glucose will help patients in managing their diabetes, thereby reducing the risk of developing complications.

Drivers

Some of the factors driving the growth of the glucose monitoring devices in Europe are:

Increasing technological innovations in diagnosis and monitoring of diabetes

Increasing incidence of people suffering from diabetes

Early detection of hypo and hyperglycemic diabetes

Increased demand for continuous glucose monitoring

Increased demand for faster, safer and effective glucose monitoring

Restraints

While there is ample scope for growth in the glucose monitoring devices market in Europe, there are some factors restraining it. These include:

High cost associated with diagnosis and treatment

Reimbursement issues

Patent expiry

Europe Glucose monitoring device market is segmented into blood glucose meters, blood glucose testing strips, lancets, and continuous glucose monitoring device and by geography into France, Italy, UK, Spain, and Germany.

This Report Offers:

Market definition for Europeglucose monitoring devices market with information on drivers and restraints.

Market Analysis involving glucose monitoring devices like blood glucose meters, blood glucose strips, lancets etc.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.

Extensively researched competitive landscape with profiles of major companies along with their market share.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

In-depth market segmentation by glucose monitoring devices (blood glucose meters, blood glucose testing strips, lancets, and continuous glucose monitoring device).

Comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade.

Wide-ranging information provided about the leading market players, major strategies adopted by them and new products launched by them.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1. INTRODUCTION
1.1 Report Description
1.2 Research Methodology
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
3.1 Market Size Estimation
3.2 Market Trends and Forecasts
3.3 MARKET DRIVERS
3.3.1 Technological Innovations
3.3.2 Convenience of CGM over conventional monitoring
3.3.3 Early Detection of Hypo and Hyperglycemic
3.3.4 Global rise in diabetic population
3.4 MARKET RESTRAINTS
3.4.1 Less Attractive Reimbursement Coverage
3.4.2 Reimbursement Issues
3.4.3 Patent expiry depleted profit of market
3.5 PorterFive Force Analysis of the Europe Glucose Monitoring Device Market
3.5.1 Bargaining power of suppliers
3.5.2 Bargaining power of buyers
3.5.3 Threat of substitutes
3.5.4 Threat of new entrants
3.5.5 Competitive rivalry
4. EUROPE GLUCOSE MONITORING DEVICE MARKET- SEGMENTATION
4.1 GLUCOSE MONITORING DEVICES
4.1.1 Blood Glucose Meter
4.1.2 Blood Glucose Testing Strips
4.1.3 Lancets
4.1.4 Continuous Glucose Monitoring Devices (CGM)
4.1.5 Others
4.2 BY GEOGRAPHY
4.2.1 France
4.2.2 Italy
4.2.3 UK
4.2.4 Germany
4.2.5 Spain
5. COMPETITIVE ANALYSIS
5.1 Introduction
5.2 Mergers & Acquisitions
5.3 Expansions
5.4 New Product Launches
5.5 Collaborations
5.6 Market Share Analysis
6. COMPANY PROFILES
6.1 Accruex Biomedical Pvt. Ltd.
6.2 Apex Biotechnology Corp.
6.3 DexCom, Inc.
6.4 F. Hoffmann-La Roche AG
6.5 LifeScan, Inc.
6.6 Medtronic Diabetes
6.7 Teco Diagnostics
6.8 Ypsomed AG
7. APPENDIX
7.1 Abbreviations
7.2 Sources
7.3 Bibliography
7.4 Disclaimer
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll